General Info

The RUNX1 Research Program is a non-profit organization committed to finding a cure for RUNX1 FPD/AML and to support patients in the RUNX1 FPD/AML community by providing a forum in which to help connect, inform and educate patients on the disorder. The RUNX1 Research Program (RRP) is a research and advocacy venture committed to funding world-class, innovative and cross-disciplinary cancer research to find a pre-leukemic cure for those with the germline RUNX1 mutation, a familial platelet disorder with a predisposition to leukemia. In addition to promoting awareness of the disorder, the program also aims to support, inform, educate and connect patients in the RUNX1 community.